Comments to the National Medical Products Administration (NMPA) on the Circular on Tightening the Regulation of Marketing Authorisation Holders for Entrusted Production of Drugs

2023-06-23 | Beijing, Shanghai

On 23rd June, European Chamber Pharmaceutical Working Group submitted comments to the National Medical Products Administration (NMPA) on the Circular on Tightening the Regulation of Marketing Authorisation Holders for Entrusted Production of Drugs.

Member companies commented on: the manufacturing of biologics, the use of CDMO companies, and other topics, and offered suggestions.